Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

3(50.0%)

N/A

2(33.3%)

Early Phase 1

1(16.7%)

6Total

Phase 1(3)

N/A(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03767361Early Phase 1Completed

Study the Effect of Blood Transfusion on Oxidant-antioxidant Status in Term and Near-term Neonates

Role: lead

NCT04391478Phase 1Completed

Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension

Role: lead

NCT04373980Not ApplicableCompleted

Conventional Versus LED Phototherapy and Their Effect on Lymphocytes Subsets of Full Term Neonates With Hyperbilirubinemia

Role: lead

NCT03302338Phase 1Unknown

Simulated Amniotic Fluid Solution in Neonates Recovering From GIT Surgeries

Role: lead

NCT03074292Not ApplicableUnknown

Comparison Between Effect of Conventional, Intensive and Light Emitting Diodes (LED) Phototherapy on Oxidative Stress Among Neonates With Unconjugated Hyperbilirubinemia

Role: lead

NCT02405637Phase 1Unknown

Simulated Amniotic Fluid In Preventing Feeding Intolerance and Necrotizing Enterocolitis VLBW Neonates

Role: lead

All 6 trials loaded